On June 17, 2021, a series of amendments to the Federal Courts Rules (the Amended Rules), were registered and came into force. On July 7, 2021, the Amended Rules were officially published in the Canada Gazette Part II.
Federal Court
Federal Court Issues Consolidated IP Guidelines


On May 18, 2021, the Federal Court (FC) issued amended Case and Trial Management Guidelines for Complex Proceedings (the Updated FC Guidelines).
As we previously reported, the FC first issued the FC Guidelines to consolidate and…
Federal Courts update guidance on COVID-19

The Federal Court of Appeal (FCA) provided updated guidance for resuming hearings starting September 1, 2020 and clarified the effect of the federal Time Limits and Other Periods Act (COVID-19) on timelines for commencing and conducting litigation in…
Federal Courts begin to phase out the Suspension Period

On June 11, 2020 the Federal Court (FC) and Federal Court of Appeal (FCA) published updated notices to gradually phase out the Suspension Period, which had previously been extended to June 15, 2020.
Federal Court
The…
Federal Courts Extend Suspension Periods to June 15

The Federal Court of Appeal (FCA) and the Federal Court (FC) have extended their Suspension Periods to June 15, 2020.
Federal Court of Appeal
On May 28, 2020, the FCA issued a Notice to the Parties…
Federal Court comments on the admissibility of ‘but for’ world s. 8 evidence and rejects generic pipefill claim

Case: Eli Lilly Canada Inc et al v Teva Canada Limited, 2017 FC 88
Drug: ZYPREXA® (olanzapine)
Nature of case: Action pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 (the Regulations)…